Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behçet's disease

Scandinavian Journal of Rheumatology

Volumn 44, Issue 2, 2015, Pages 163-167

  Kolahi, S ^a   Khabbazi, A ^a   Khodadadi, H ^b   Estiar, M ^c   Hajialiloo, M ^d   Emrahi, L ^d   Sakhinia, E ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IRANIAN PEOPLE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; BEHCET SYNDROME; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ETHNOLOGY; GENETICS; IRAN;

ADULT; ALLELES; BEHCET SYNDROME; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IRAN; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL;

EID: 84928824468     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.945477     Document Type: Article

References (43)

1. Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Moradi M, et al. Prevalence of Behçet's disease in Iran: a WHO-ILAR COPCORD stage I study. APLAR J Rheumatol 2007;10:239-43
2. Davatchi F, Jamshidi A-R, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol 2008;35:1384-90
3. Karatay S, Yildirim K, Karakuzu A, Kiziltunc A, Engin RI, Eren YB, et al. Vitamin D status in patients with Behçet's disease. Clinics 2011;66:721-3
4. Faezi ST, Ansari N, Paragomi P, Akhlaghi M, Ghanavat M, Davatchi F. Vitamin D deficiency in patients with Behçet's disease. J Diabetes Metab Disord 2014;13:18
5. Hamzaoui K, Ben Dhifallah I, Karray E, Sassi F, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Behçet's disease. Clin Exp Rheumatol 2009;28:S50-7
6. Do JE, Kwon SY, Park S, Lee E-S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology (Oxford) 2008;47:840-8
7. Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, Hajialiloo M, Ghojazadeh M, Taei R, et al. The status of serum vitamin D in patients with active Behçet's disease compared with controls. Int J Rheum Dis 2014;17:430-4
8. Rigby W, Waugh M, Graziano R. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 1990;76:189-97
9. Berer A, Stöckl J, Majdic O, Wagner T, Kollars M, Lechner K, et al. 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000;28:575-83
10. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 2000;270:701-8
11. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-62
12. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25- Dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334-8
13. Provvedini D, Tsoukas C, Deftos L, Manolagas S. 1,25- Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181-3
14. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22:203-17
15. Zhang J, Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, et al. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol 2011;18:556-63
16. Štefanic M, Karner I, GlavaS-Obrovac L, Papic S, Vrdoljak D, Levak G, et al. Association of vitamin D receptor gene polymorphism with susceptibility toGraves' disease in Eastern Croatian population: casecontrol study. Croat Med J 2005; 46:639-46
17. Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease. Acta Biochim Pol 2008;55:371-80
18. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008;11:134-9
19. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111-32
20. Mostowska A, Lianeri M, Wudarski M, Olesi?ska M, Jagodziski PP. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 2013;40:803-10
21. Lee YH, Bae S-C, Choi SJ, Ji JD, Song GG. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-Analysis. Mol Biol Rep 2011;38:3643-51
22. Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, et al. Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 2012;39:1792-7
23. Feng M, Li H, Chen S-F, Li W-F, Zhang F-B. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-Analysis. Endocrine 2013;43:318-26
24. Bid HK, Konwar R, Aggarwal C, Gautam S, Saxena M, Nayak VL, Banerjee M. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 2009;63:187-94
25. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143-56
26. Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, et al. Associations of vitamin Dreceptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians. Joint Bone Spine 2012;79:144-8
27. Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi- Abdollahi B, Schirmer M, et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-47
28. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49:504-7
29. Aslani S, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Afshar AN, Karimi F. VDR FokI polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecol Endocrinol 2011;27:1055-60
30. Capoluongo E, Pitocco D, Concolino P, Santonocito C, Di Stasio E, d'Onofrio G, et al. Slight association between type 1 diabetes and 'ff' VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 2006;39:888-92
31. Pani MA, Seissler J, Usadel K-H, Badenhoop K. VitaminD receptor genotype is associated with Addison's disease. Eur J Endocrinol 2002;147:635-40
32. Mohammadnejad Z, Ghanbari M, Ganjali R, Afshari JT, Heydarpour M, Taghavi SM, et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep 2012;39:831-7
33. Lemos MC, Fagulha A, Coutinho E, Gomes L, Bastos M, Barros L, et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol 2008;69:134-8
34. Fassbender W, Goertz B, Weismuller K, Steinhauer B, Stracke H, Auch D, et al. VDR gene polymorphisms are overrepresented in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res 2002;34:330-7
35. Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol 2009;207:117-21
36. Abbasi M, Rezaieyazdi Z, Afshari JT, Hatef M, Sahebari M, Saadati N. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 2010;30:1537-9
37. Niksresht A, Dadkhah B, Sarvestani EK. The association of vitamin D receptor gene BsmI polymorphism with multiple sclerosis in Iranian patients. J Kerman Univ Med Sci 2009;16:116-23
38. Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, et al. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 2011;10:3
39. Sakulpipatsin W, Verasertniyom O, Nantiruj K, Totemchokchyakarn K, Lertsrisatit P, Janwityanujit S. Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 2006;8:R48.
40. Huang C, Wu M, Wu J, Tsai F. Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002;11:31-4
41. Malecki M, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 2003;111:505-9
42. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh J-C, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000; 14:401-20
43. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HA, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin Endocrinol 2000;52:211-16